Zealand Pharma A/S reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was DKK 28.37 million compared to DKK 36.55 million a year ago. Net loss was DKK 488.5 million compared to DKK 296.82 million a year ago. Basic loss per share from continuing operations was DKK 9.77 compared to DKK 6.88 a year ago. Basic loss per share was DKK 11.04 compared to DKK 6.87 a year ago.
For the six months, sales was DKK 43.45 million compared to DKK 42.25 million a year ago. Net loss was DKK 711.35 million compared to DKK 539 million a year ago. Basic loss per share from continuing operations was DKK 14.03 compared to DKK 12.67 a year ago. Basic loss per share was DKK 16.27 compared to DKK 12.66 a year ago.